159183-36-5Relevant articles and documents
Chemoselective and Kilogram-Scale Synthesis of Acetanilide β3-Adrenergic Receptor Agonist
Kawazoe, Souichirou,Suzuki, Takayuki,Nakamura, Hirofumi,Sugimori, Toshiyuki,Onda, Kenichi,Maruyama, Tatsuya,Okada, Minoru
, p. 139 - 145 (2015/01/30)
We describe an alternative route for the synthesis of β3-adrenergic receptor agonist (S)-2-(2-phenylamino-1,3- thiazol-4-yl)-4′-{2-[(2-hydroxy-3-phenoxypropyl)amino]ethyl}acetanilide (1). The key intermediate (S)-1-{[2-(4-aminophenyl)ethyl]amin
Discovery of a novel, potent and selective human β3- adrenergic receptor agonist
Nakajima, Yutaka,Hamashima, Hitoshi,Washizuka, Ken-Ichi,Tomishima, Yasuyo,Ohtake, Hiroaki,Imamura, Emiko,Miura, Toshiko,Kayakiri, Hiroshi,Kato, Masayuki
, p. 251 - 254 (2007/10/03)
Design and structure-activity relationships of a novel β3- adrenergic receptor agonist are described. The discovery of a novel, potent and selective β3-adrenergic receptor (AR) agonist is described. SAR studies demonstrated the struc
Potent, selective aminothiazolidinediones agonists of the human β3 Adrenergic receptor
Malamas,Largis,Gunawan,Li,Tillett,Han,Mulvey
, p. 164 - 177 (2007/10/03)
A cloned human β3 adrenergic receptor assay was used to identify potent and selective β3 agonists. The thiazolidinedione moiety has been identified as a new pharmacophore for the human β3 adrenergic receptor. The versatility of the thiazolidinedione pharmacophore was demonstrated in both the arylethanolamine and phenylpropanolamine families of β3 agonists, where potent and selective compounds have been synthesized. Thiazolidinedione 20, a potent and selective human β3 agonist, increased thermogenesis and lowered plasma glucose levels in the db/db mice.